0.45
-0.12(-26.67%)
Currency In USD
| Previous Close | 0.45 |
| Open | 0.33 |
| Day High | 0.45 |
| Day Low | 0.33 |
| 52-Week High | 3.87 |
| 52-Week Low | 0.01 |
| Volume | 310 |
| Average Volume | 3,053.7 |
| Market Cap | 5.85M |
| PE | 5 |
| EPS | 0.09 |
| Moving Average 50 Days | 0.83 |
| Moving Average 200 Days | 2.08 |
| Change | -0.12 |
If you invested $1000 in Eagle Pharmaceuticals, Inc. (EGRX) 10 years ago, it would be worth $5.14 as of December 24, 2025 at a share price of $0.45. Whereas If you bought $1000 worth of Eagle Pharmaceuticals, Inc. (EGRX) shares 5 years ago, it would be worth $9.74 as of December 24, 2025 at a share price of $0.45.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan
GlobeNewswire Inc.
Oct 30, 2025 10:50 AM GMT
WOODCLIFF LAKE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its Board of Directors (the “Board”) has adopted an amendment (the “Amendment”) to its existing limi
Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders
GlobeNewswire Inc.
Oct 21, 2025 8:05 PM GMT
WOODCLIFF LAKE, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) is pleased to announce the voting results for each of the matters presented at the Company’s 2025 annual meeting of stock
Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements
GlobeNewswire Inc.
Oct 15, 2025 8:30 PM GMT
WOODCLIFF LAKE, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that the Company’s unaudited financial statements for the three and six months ended June 30, 2025, are a